Corcept Therapeutics Inc (NASDAQ: CORT) is 10.12% higher on its value in year-to-date trading and has touched a low of $20.84 and a high of $75.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CORT stock was last observed hovering at around $55.99 in the last trading session, with the day’s loss setting it -0.5%.
Currently trading at $55.49, the stock is -15.20% and -7.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing -0.89% at the moment leaves the stock 21.66% off its SMA200. CORT registered 130.63% gain for a year compared to 6-month gain of 57.20%.
The stock witnessed a -16.62% loss in the last 1 month and extending the period to 3 months gives it a -3.80%, and is -12.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.23% over the week and 5.26% over the month.
Corcept Therapeutics Inc (CORT) has around 500 employees, a market worth around $5.85B and $675.04M in sales. Current P/E ratio is 45.00 and Fwd P/E is 15.66. Profit margin for the company is 20.70%. Distance from 52-week low is 166.27% and -26.01% from its 52-week high. The company has generated returns on investments over the last 12 months (20.38%).
The EPS is expected to grow by 55.26% this year
The shares outstanding are 105.11M, and float is at 93.10M with Short Float at 16.53%.
The top institutional shareholder in the company is BLACKROCK INC. with over 16.54 million shares valued at $537.36 million. The investor’s holdings represent 16.0901 of the CORT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 9.55 million shares valued at $310.4 million to account for 9.2943 of the shares outstanding. The other top investors are INGALLS & SNYDER LLC which holds 8.24 million shares representing 7.989 and valued at over $267.66 million, while RENAISSANCE TECHNOLOGIES LLC holds 6.7036 of the shares totaling 6.91 million with a market value of $224.59 million.
Corcept Therapeutics Inc (CORT) Insider Activity
A total of 0 insider transactions have happened at Corcept Therapeutics Inc (CORT) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Maduck Sean,. SEC filings show that Maduck Sean sold 18,303 shares of the company’s common stock on Mar 03 ’25 at a price of $60.69 per share for a total of $1.11 million. Following the sale, the insider now owns 85622.0 shares.
Corcept Therapeutics Inc disclosed in a document filed with the SEC on Mar 03 ’25 that Lyon Joseph Douglas sold a total of 4,579 shares of the company’s common stock. The trade occurred on Mar 03 ’25 and was made at $60.69 per share for $0.28 million. Following the transaction, the insider now directly holds 9009.0 shares of the CORT stock.
Still, SEC filings show that on Mar 04 ’25, Guyer William (Chief Development Officer) disposed off 20,000 shares at an average price of $59.07 for $1.18 million. The insider now directly holds 5,487 shares of Corcept Therapeutics Inc (CORT).
Corcept Therapeutics Inc (CORT): Who are the competitors?
One of the company’s main competitors (and peers) include Eli Lilly & Co. (LLY) that is trading 19.23% up over the past 12 months.Johnson & Johnson (JNJ) lies in the list of competitors of the Corcept Therapeutics Inc and is 3.63% higher over the same period from CORTBristol Myers Squibb Co. (BMY) is 12.06% up on the 1-year trading charts.
